Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine pharmacokinetics and pharmacogenomics in chronic pain patients
ACTRN12613000327785Phase 3Completed
- Sponsor
- Andrew Somogyi
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ketamine in chronic pain, sponsored by Andrew Somogyi. Primary endpoint: Relationship of plasma ketamine and/or norketamine concentrations to analgesic efficacy and adverse effects. Started Oct 2012; status: completed.
02
Drugs
ketamine
03
Conditions
chronic pain
Beyond the preview
Go deeper on ACTRN12613000327785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000327785.